{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:54:29Z","timestamp":1788836069473,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"EUROFARMA"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43963-1","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:16:04Z","timestamp":1775805364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the efficacy of delafloxacin and combination therapy against Staphylococcus aureus Biofilms: insights into activity in acidic environments"],"prefix":"10.1038","volume":"16","author":[{"given":"Ana Paula","family":"de Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Hansen","family":"Suss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline Pilon","family":"de Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Burato","family":"Ortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Francisco","family":"Tuon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"1","key":"43963_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jos.2022.11.022","volume":"29","author":"MA Pedroni","year":"2024","unstructured":"Pedroni, M. A. et al. Different concentrations of vancomycin with gentamicin loaded PMMA to inhibit biofilm formation of Staphylococcus aureus and their implications. J. Orthop. Sci. 29(1), 334\u2013340 (2024).","journal-title":"J. Orthop. Sci."},{"issue":"Suppl 6","key":"43963_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2023.02.032","volume":"54","author":"JF Soni","year":"2023","unstructured":"Soni, J. F. et al. Evaluation of silver nanoparticle-impregnated PMMA loaded with vancomycin or gentamicin against bacterial biofilm formation. Injury 54(Suppl 6), 110649 (2023).","journal-title":"Injury"},{"issue":"3","key":"43963_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bjid.2019.05.006","volume":"23","author":"JP Telles","year":"2019","unstructured":"Telles, J. P., Cieslinski, J. & Tuon, F. F. Daptomycin to bone and joint infections and prosthesis joint infections: A systematic review. Braz. J. Infect. Dis. 23(3), 191\u2013196 (2019).","journal-title":"Braz. J. Infect. Dis."},{"issue":"9","key":"43963_CR4","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1016\/j.ijid.2010.01.005","volume":"14","author":"R Haidar","year":"2010","unstructured":"Haidar, R., Der Boghossian, A. & Atiyeh, B. Duration of post-surgical antibiotics in chronic osteomyelitis: Empiric or evidence-based?. Int. J. Infect. Dis. 14(9), e752\u2013e758 (2010).","journal-title":"Int. J. Infect. Dis."},{"key":"43963_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010087","author":"FF Tuon","year":"2023","unstructured":"Tuon, F. F. et al. Antimicrobial treatment of Staphylococcus aureus biofilms. Antibiotics https:\/\/doi.org\/10.3390\/antibiotics12010087 (2023).","journal-title":"Antibiotics"},{"key":"43963_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11030300","author":"FF Tuon","year":"2022","unstructured":"Tuon, F. F., Dantas, L. R., Suss, P. H. & Tasca Ribeiro, V. S. Pathogenesis of the Pseudomonas aeruginosa biofilm: A review. Pathogens https:\/\/doi.org\/10.3390\/pathogens11030300 (2022).","journal-title":"Pathogens"},{"key":"43963_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/life10110253","author":"JA Koch","year":"2020","unstructured":"Koch, J. A. et al. Staphylococcus epidermidis biofilms have a high tolerance to antibiotics in periprosthetic joint infection. Life https:\/\/doi.org\/10.3390\/life10110253 (2020).","journal-title":"Life"},{"key":"43963_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101278","author":"R Yee","year":"2022","unstructured":"Yee, R. et al. Eradication of Staphylococcus aureus biofilm infection by persister drug combination. Antibiotics (Basel) https:\/\/doi.org\/10.3390\/antibiotics11101278 (2022).","journal-title":"Antibiotics (Basel)"},{"key":"43963_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01822-16","author":"CL Brinkman","year":"2017","unstructured":"Brinkman, C. L., Schmidt-Malan, S. M., Mandrekar, J. N. & Patel, R. Rifampin-based combination therapy is active in foreign-body osteomyelitis after prior rifampin monotherapy. Antimicrob. Agent. Chemother. https:\/\/doi.org\/10.1128\/AAC.01822-16 (2017).","journal-title":"Antimicrob. Agent. Chemother."},{"issue":"7","key":"43963_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/jor.24291","volume":"37","author":"JB Mandell","year":"2019","unstructured":"Mandell, J. B. et al. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates. J. Orthop. Res. 37(7), 1604\u20131609 (2019).","journal-title":"J. Orthop. Res."},{"issue":"12","key":"43963_CR11","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/jac\/dkac311","volume":"77","author":"MA Melendez-Carmona","year":"2022","unstructured":"Melendez-Carmona, M. A. et al. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin. J. Antimicrob. Chemother. 77(12), 3265\u20133269 (2022).","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"43963_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ijantimicag.2019.06.018","volume":"54","author":"MA Melendez-Carmona","year":"2019","unstructured":"Melendez-Carmona, M. A., Munoz-Gallego, I., Viedma, E., Lora-Tamayo, J. & Chaves, F. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection. Int. J. Antimicrob. Agents 54(3), 356\u2013360 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"43963_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijantimicag.2016.05.021","volume":"48","author":"J Lora-Tamayo","year":"2016","unstructured":"Lora-Tamayo, J. et al. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: A randomised clinical trial. Int. J. Antimicrob. Agent. 48(3), 310\u2013316 (2016).","journal-title":"Int. J. Antimicrob. Agent."},{"key":"43963_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081241","author":"A Turban","year":"2023","unstructured":"Turban, A., Guerin, F., Dinh, A. & Cattoir, V. Updated review on clinically-relevant properties of delafloxacin. Antibiotics https:\/\/doi.org\/10.3390\/antibiotics12081241 (2023).","journal-title":"Antibiotics"},{"issue":"6","key":"43963_CR15","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1128\/AAC.00181-13","volume":"57","author":"J Bauer","year":"2013","unstructured":"Bauer, J., Siala, W., Tulkens, P. M. & Van Bambeke, F. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. Antimicrob. Agent. Chemother. 57(6), 2726\u20132737 (2013).","journal-title":"Antimicrob. Agent. Chemother."},{"issue":"2","key":"43963_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.01201-10","volume":"55","author":"S Lemaire","year":"2011","unstructured":"Lemaire, S., Tulkens, P. M. & Van Bambeke, F. Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus. Antimicrob. Agent. Chemother. 55(2), 649\u2013658 (2011).","journal-title":"Antimicrob. Agent. Chemother."},{"key":"43963_CR17","unstructured":"CLSI Clinical laboratory standard insitute - M07 - A10 - Methods for dilution antimicrobial suceptibility tests for bacteria that grow aerobically (2015)."},{"key":"43963_CR18","unstructured":"EUCAST Clinical breakpoint. European Committee on antimicrobial susceptibility testing version 11 (2021)."},{"issue":"1","key":"43963_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan, G., Bayram, A., Zer, Y. & Balci, I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J. Clin. Microbiol. 43(1), 140\u2013143 (2005).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"43963_CR20","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/jac\/dkac102","volume":"77","author":"V Chaiben","year":"2022","unstructured":"Chaiben, V. et al. A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: An in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam. J. Antimicrob. Chemother. 77(6), 1676\u20131684 (2022).","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"43963_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/154.4.670","volume":"154","author":"EG Chadwick","year":"1986","unstructured":"Chadwick, E. G., Shulman, S. T. & Yogev, R. Correlation of antibiotic synergy in vitro and in vivo: Use of an animal model of neutropenic gram-negative sepsis. J. Infect. Dis. 154(4), 670\u2013675 (1986).","journal-title":"J. Infect. Dis."},{"issue":"4","key":"43963_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens6040062","volume":"6","author":"CF Rodrigues","year":"2017","unstructured":"Rodrigues, C. F. & Henriques, M. Liposomal and Deoxycholate Amphotericin B formulations: Effectiveness against biofilm infections of Candida spp. Pathogens 6(4), 62 (2017).","journal-title":"Pathogens"},{"issue":"7","key":"43963_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/08927014.2011.602188","volume":"27","author":"C Traba","year":"2011","unstructured":"Traba, C. & Liang, J. F. Susceptibility of Staphylococcus aureus biofilms to reactive discharge gases. Biofouling 27(7), 763\u2013772 (2011).","journal-title":"Biofouling"},{"issue":"6","key":"43963_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/jcm.22.6.996-1006.1985","volume":"22","author":"GD Christensen","year":"1985","unstructured":"Christensen, G. D. et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22(6), 996\u20131006 (1985).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"43963_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00590-020-02856-3","volume":"31","author":"J Cieslinski","year":"2021","unstructured":"Cieslinski, J. et al. Direct detection of microorganisms in sonicated orthopedic devices after in vitro biofilm production and different processing conditions. Eur. J. Orthop. Surg. Traumatol. 31(6), 1113\u20131120 (2021).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"5","key":"43963_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00590-021-03069-y","volume":"32","author":"L da Rocha","year":"2022","unstructured":"da Rocha, L. et al. Evaluation of Staphylococcus aureus and Candida albicans biofilms adherence to PEEK and titanium-alloy prosthetic spine devices. Eur. J. Orthop. Surg. Traumatol. 32(5), 981\u2013989 (2022).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"5","key":"43963_CR27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/opo.13189","volume":"43","author":"JR Mendonca","year":"2023","unstructured":"Mendonca, J. R., Dantas, L. R. & Tuon, F. F. Activity of multipurpose contact lens solutions against Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens and Candida albicans biofilms. Ophthalmic Physiol. Opt. 43(5), 1092\u20131099 (2023).","journal-title":"Ophthalmic Physiol. Opt."},{"issue":"6","key":"43963_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01269-22","volume":"10","author":"R Sikdar","year":"2022","unstructured":"Sikdar, R. & Elias, M. H. Evidence for complex interplay between quorum sensing and antibiotic resistance in Pseudomonas aeruginosa. Microbiol. Spectr. 10(6), e0126922 (2022).","journal-title":"Microbiol. Spectr."},{"key":"43963_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0612-5","volume":"8","author":"R Ranjbar","year":"2019","unstructured":"Ranjbar, R. & Farahani, A. Study of genetic diversity, biofilm formation, and detection of carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrob. Resist. Infect. Control. 8, 172 (2019).","journal-title":"Antimicrob. Resist. Infect. Control."},{"issue":"6","key":"43963_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.arth.2019.02.020","volume":"34","author":"N Ueda","year":"2019","unstructured":"Ueda, N. et al. Sonication of extracted implants improves microbial detection in patients with orthopedic implant-associated infections. J. Arthroplasty 34(6), 1189\u20131196 (2019).","journal-title":"J. Arthroplasty"},{"issue":"4","key":"43963_CR31","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1128\/AAC.04359-14","volume":"59","author":"F Valour","year":"2015","unstructured":"Valour, F. et al. Antimicrobial activity against intraosteoblastic Staphylococcus aureus. Antimicrob. Agents Chemother. 59(4), 2029\u20132036 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"43963_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.diagmicrobio.2014.05.022","volume":"80","author":"J Lora-Tamayo","year":"2014","unstructured":"Lora-Tamayo, J. et al. High doses of daptomycin (10 mg\/kg\/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study. Diagn. Microbiol. Infect. Dis. 80(1), 66\u201371 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"6","key":"43963_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijantimicag.2013.02.018","volume":"41","author":"D Molina-Manso","year":"2013","unstructured":"Molina-Manso, D. et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int. J. Antimicrob. Agents 41(6), 521\u2013523 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"43963_CR34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/jac\/dkt067","volume":"68","author":"RA Seaton","year":"2013","unstructured":"Seaton, R. A. et al. Daptomycin use in patients with osteomyelitis: A preliminary report from the EU-CORE(SM) database. J. Antimicrob. Chemother. 68(7), 1642\u20131649 (2013).","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"43963_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2106\/JBJS.16.01002","volume":"99","author":"JM Thompson","year":"2017","unstructured":"Thompson, J. M. et al. Oral-only linezolid-rifampin is highly effective compared with other antibiotics for periprosthetic joint infection: Study of a mouse model. J. Bone Joint Surg. Am. 99(8), 656\u2013665 (2017).","journal-title":"J. Bone Joint Surg. Am."},{"issue":"5","key":"43963_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.medcli.2017.04.031","volume":"149","author":"S Herrera","year":"2017","unstructured":"Herrera, S., Sorli, L. & Horcajada, J. P. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections. Med Clin (Barc) 149(5), 223\u2013224 (2017).","journal-title":"Med Clin (Barc)"},{"issue":"8","key":"43963_CR37","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1128\/AAC.00735-16","volume":"60","author":"R Boudjemaa","year":"2016","unstructured":"Boudjemaa, R. et al. New insight into daptomycin bioavailability and localization in Staphylococcus aureus biofilms by dynamic fluorescence imaging. Antimicrob. Agent. Chemother. 60(8), 4983\u20134990 (2016).","journal-title":"Antimicrob. Agent. Chemother."},{"issue":"4","key":"43963_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s15010-016-0874-2","volume":"44","author":"C Stein","year":"2016","unstructured":"Stein, C. et al. Should daptomycin-rifampin combinations for MSSA\/MRSA isolates be avoided because of antagonism?. Infection 44(4), 499\u2013504 (2016).","journal-title":"Infection"},{"issue":"10","key":"43963_CR39","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1128\/AAC.00675-11","volume":"55","author":"A Saleh-Mghir","year":"2011","unstructured":"Saleh-Mghir, A., Muller-Serieys, C., Dinh, A., Massias, L. & Cremieux, A. C. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agent. Chemother. 55(10), 4589\u20134593 (2011).","journal-title":"Antimicrob. Agent. Chemother."},{"issue":"9","key":"43963_CR40","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/jac\/dkaa209","volume":"75","author":"LD Saravolatz","year":"2020","unstructured":"Saravolatz, L. D., Pawlak, J. M. & Wegner, C. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. J. Antimicrob. Chemother. 75(9), 2605\u20132608 (2020).","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"43963_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07376-2","volume":"22","author":"JAW Cruz","year":"2022","unstructured":"Cruz, J. A. W. et al. Brazilian private health system: History, scenarios, and trends. BMC Health Serv. Res. 22(1), 49 (2022).","journal-title":"BMC Health Serv. Res."},{"issue":"12","key":"43963_CR42","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1017\/ice.2021.22","volume":"42","author":"GH Loesch","year":"2021","unstructured":"Loesch, G. H. et al. Cost minimization analysis of outpatient parenteral\/oral antibiotic therapy at a trauma hospital: Public health system. Infect. Control Hosp. Epidemiol. 42(12), 1445\u20131450 (2021).","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"3","key":"43963_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04190-22","volume":"11","author":"F Coustilleres","year":"2023","unstructured":"Coustilleres, F. et al. Clinical, bacteriological, and genetic characterization of bone and joint infections involving linezolid-resistant Staphylococcus epidermidis: A retrospective multicenter study in French reference centers. Microbiol. Spectr. 11(3), e0419022 (2023).","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"43963_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/17512433.2022.2100346","volume":"15","author":"S Gomez-Zorrilla","year":"2022","unstructured":"Gomez-Zorrilla, S., Sendra, E. & Horcajada, J. P. A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia. Expert Rev. Clin. Pharmacol. 15(6), 671\u2013688 (2022).","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1","key":"43963_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-0200-0","volume":"10","author":"KC Fan","year":"2020","unstructured":"Fan, K. C. et al. In vitro susceptibilities of methicillin-susceptible and resistant staphylococci to traditional antibiotics compared to a novel fluoroquinolone. J. Ophthalmic Inflamm. Infect. 10(1), 9 (2020).","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"43963_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ma17133349","author":"M Fernandez-Grajera","year":"2024","unstructured":"Fernandez-Grajera, M., Pacha-Olivenza, M. A., Fernandez-Calderon, M. C., Gonzalez-Martin, M. L. & Gallardo-Moreno, A. M. Dynamic adhesive behavior and biofilm formation of Staphylococcus aureus on polylactic acid surfaces in diabetic environments. Materials https:\/\/doi.org\/10.3390\/ma17133349 (2024).","journal-title":"Materials"},{"issue":"2","key":"43963_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.37201\/req\/107.2023","volume":"37","author":"E Rios","year":"2024","unstructured":"Rios, E., Perez, M., Sanz, J. C., Delgado-Iribarren, A. & Rodriguez-Avial, I. Efficacy of delafloxacin alone and in combination with cefotaxime against cefotaxime non-susceptible invasive isolates of Streptococcus pneumoniae. Rev. Esp. Quimioter. 37(2), 158\u2013162 (2024).","journal-title":"Rev. Esp. Quimioter."},{"issue":"11","key":"43963_CR48","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1128\/AAC.03482-14","volume":"58","author":"W Siala","year":"2014","unstructured":"Siala, W. et al. Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother. 58(11), 6385\u20136397 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"43963_CR49","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.tim.2025.04.012","volume":"33","author":"S Vareschi","year":"2025","unstructured":"Vareschi, S., Jaut, V., Vijay, S., Allen, R. J. & Schreiber, F. Antimicrobial efflux and biofilms: An interplay leading to emergent resistance evolution. Trends Microbiol. 33(9), 1018\u20131032 (2025).","journal-title":"Trends Microbiol."},{"issue":"1","key":"43963_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","volume":"9","author":"R Roy","year":"2018","unstructured":"Roy, R., Tiwari, M., Donelli, G. & Tiwari, V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence 9(1), 522\u2013554 (2018).","journal-title":"Virulence"},{"key":"43963_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ram.2024.05.004","author":"J Gasparetto","year":"2024","unstructured":"Gasparetto, J., Bressianini Jurkonis, L., Ramos Dantas, L., Hansen Suss, P. & Francisco Tuon, F. Low-cost antiseptic-impregnated tracheostomy tube for the prevention of ventilator-associated pneumonia caused by multidrug-resistant bacteria: In vitro and pilot study in humans. Rev. Argent. Microbiol. https:\/\/doi.org\/10.1016\/j.ram.2024.05.004 (2024).","journal-title":"Rev. Argent. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43963-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:02:38Z","timestamp":1779753758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43963-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43963"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43963-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors received financial support by Eurofarma to develop this study. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. EUROFARMA has supported the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Ethical Committee of Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 (61738422.7.0000.0020) and informed consent was obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"16156"}}